Literature DB >> 11188885

Circulating DNA in plasma or serum.

P Anker1, M Stroun.   

Abstract

Small amounts of DNA circulate in both healthy and diseased human plasma/serum, and increased concentrations of DNA are present in the plasma of cancer patients. Characteristics of tumor DNA have been found in genetic material extracted from the plasma of cancer patients. These features include decreased strand stability, the presence of specific oncogene or tumor suppressor gene mutations, microsatellite alterations, Ig rearrangements and hypermethylation of several genes. The results obtained in many different cancers have opened a new research area indicating that plasma DNA might eventually be a suitable target for the development of noninvasive diagnostic, prognostic and follow-up tests for cancer. Following the discovery of tumor derived DNA in plasma or serum, cell-free fetal DNA has also been found in maternal plasma and serum. This discovery provides an easily accessible source of fetal genetic material for prenatal diagnosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11188885

Source DB:  PubMed          Journal:  Medicina (B Aires)        ISSN: 0025-7680            Impact factor:   0.653


  15 in total

1.  Effect of DNase and antibiotics on biofilm characteristics.

Authors:  George V Tetz; Natalia K Artemenko; Victor V Tetz
Journal:  Antimicrob Agents Chemother       Date:  2008-12-08       Impact factor: 5.191

2.  Plasma DNA integrity index as a potential molecular diagnostic marker for breast cancer.

Authors:  Azza M Kamel; Salwa Teama; Amal Fawzy; Mervat El Deftar
Journal:  Tumour Biol       Date:  2015-12-18

3.  Comparison of four DNA extraction methods for detecting Mycobacterium tuberculosis by real-time PCR and its clinical application in pulmonary tuberculosis.

Authors:  Shiyang Pan; Bing Gu; Hong Wang; Zihe Yan; Peng Wang; Hao Pei; Weiping Xie; Dan Chen; Genyan Liu
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

Review 4.  The prognostic molecular markers in hepatocellular carcinoma.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

5.  The MethDet: a technology for biomarker development.

Authors:  Victor V Levenson; Anatoliy A Melnikov
Journal:  Expert Rev Mol Diagn       Date:  2011-11       Impact factor: 5.225

Review 6.  Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-17       Impact factor: 4.553

Review 7.  Immune Reactivation by Cell-Free Fetal DNA in Healthy Pregnancies Re-Purposed to Target Tumors: Novel Checkpoint Inhibition in Cancer Therapeutics.

Authors:  Elizabeth Ann L Enninga; Wendy K Nevala; Shernan G Holtan; Svetomir N Markovic
Journal:  Front Immunol       Date:  2015-08-26       Impact factor: 7.561

8.  Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection.

Authors:  Kyongchol Kim; Dong Gue Shin; Min Koo Park; Seung Hyuk Baik; Tae Hee Kim; Sanghee Kim; Saeyoung Lee
Journal:  Ann Surg Treat Res       Date:  2014-02-24       Impact factor: 1.859

Review 9.  Free DNA--new potential analyte in clinical laboratory diagnostics?

Authors:  Jasenka Wagner
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

10.  Quantification of cell-free DNA for evaluating genotoxic damage from occupational exposure to car paints.

Authors:  Mónica Villalba-Campos; Sandra Rocío Ramírez-Clavijo; Magda Carolina Sánchez-Corredor; Milena Rondón-Lagos; Milcíades Ibáñez-Pinilla; Ruth Marien Palma; Marcela Eugenia Varona-Uribe; Lilian Chuaire-Noack
Journal:  J Occup Med Toxicol       Date:  2016-07-15       Impact factor: 2.646

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.